Literature DB >> 2022305

Increased matrix gene expression by glucose in rat neural connective tissue cells in culture.

P Muona1, J Peltonen, S Jaakkola, J Uitto.   

Abstract

The effects of different glucose concentrations on the expression of extracellular matrix genes were examined in primary cell cultures initiated from sciatic nerves of nondiabetic Sprague-Dawley rats. The cells were incubated in medium containing 5.5, 15, or 25 mM D-glucose, and the expression of type I and IV collagens, laminin, and fibronectin genes was examined at mRNA steady-state levels by Northern hybridizations. Incubation of cell cultures, consisting of Schwann cells, perineurial cells, and fibroblasts, in high glucose concentrations (15 or 25 mM D-glucose) resulted in elevation of pro-alpha 1(IV), pro-alpha 2(IV), and pro-alpha 1(I) collagen chain and fibronectin mRNAs after only 3 days of incubation, whereas laminin B2 chain mRNA levels appeared unaltered. These observations suggest that hyperglycemia may partially contribute to basement membrane thickening in peripheral nerves of diabetic individuals by increasing the expression of genes coding for basement membrane components, e.g., type IV collagen.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022305     DOI: 10.2337/diab.40.5.605

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  3 in total

1.  Hyperglycemic glucose concentrations up-regulate the expression of type VI collagen in vitro. Relevance to alterations of peripheral nerves in diabetes mellitus.

Authors:  P Muona; S Jaakkola; R Z Zhang; T C Pan; L Pelliniemi; L Risteli; M L Chu; J Uitto; J Peltonen
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

2.  Extracellular matrix remodelling in human diabetic neuropathy.

Authors:  Rebecca Hill
Journal:  J Anat       Date:  2009-02       Impact factor: 2.610

Review 3.  Diabetic fibrosis.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-12-28       Impact factor: 5.187

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.